Clinical Trials on Cutaneous Nerves CNS Itch in United Kingdom
Total 1753 results
-
University of MinnesotaCompletedCutaneous Nerves CNS ItchUnited States
-
BiogenCompletedMultiple Sclerosis | Central Nervous System (CNS) Demyelinating DiseaseUnited Kingdom
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
University of OxfordMultiple Sclerosis Society of Great Britain and Northern IrelandCompletedMultiple Sclerosis | Optic NeuritisUnited Kingdom
-
Jonsson Comprehensive Cancer CenterBristol-Myers Squibb; Array BioPharmaRecruitingMetastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous... and other conditionsUnited States
-
Oxford Brookes UniversityGuy's and St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS... and other collaboratorsRecruitingMultiple Sclerosis | Neuromyelitis OpticaUnited Kingdom
-
University of AberdeenNHS GrampianCompletedAbdominal Pain | Abdominal Cutaneous Nerve Entrapment SyndromeUnited Kingdom
-
University College, LondonNational Multiple Sclerosis Society; Multiple Sclerosis Society of Great Britain...Completed
-
SanofiCompletedMultiple SclerosisUnited Kingdom
-
Queen Mary University of LondonCompleted
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited Kingdom
-
Queen Margaret UniversityRecruitingMultiple SclerosisUnited Kingdom
-
University of EdinburghCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
Jazz PharmaceuticalsCompletedMultiple SclerosisUnited Kingdom
-
Imperial College LondonCompletedMultiple SclerosisUnited Kingdom
-
Queen Mary University of LondonNovartis Pharmaceuticals; University College, London; Barts & The London NHS... and other collaboratorsCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage 0 Cutaneous Melanoma AJCC v8 | Clinical Stage I Cutaneous Melanoma AJCC v8 | Clinical Stage IA Cutaneous Melanoma AJCC v8 | Clinical... and other conditionsUnited States
-
University of NottinghamUniversity of Lincoln; MS SocietyRecruitingMultiple SclerosisUnited Kingdom
-
University of LincolnUniversity of Nottingham; National University of Ireland, Maynooth; University... and other collaboratorsRecruitingMultiple SclerosisUnited Kingdom
-
Nottingham University Hospitals NHS TrustCompleted
-
Jazz PharmaceuticalsCompletedMultiple SclerosisUnited Kingdom
-
Queen Mary University of LondonRoche Pharma AG; Barts & The London NHS TrustCompleted
-
Cardiff UniversityCompletedMultiple SclerosisUnited Kingdom
-
GlaxoSmithKlineTerminated
-
King's College LondonNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited Kingdom
-
University College, LondonCompletedStroke | Atrial Fibrillation (AF) | Intracerebral Haemorrhage (ICH)United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingClinical Stage I Cutaneous Melanoma AJCC v8 | Clinical Stage IA Cutaneous Melanoma AJCC v8 | Clinical Stage IB Cutaneous Melanoma AJCC v8 | Clinical Stage II Cutaneous Melanoma AJCC v8 | Clinical Stage IIA Cutaneous Melanoma AJCC v8 | Clinical Stage IIB Cutaneous Melanoma AJCC v8 | Clinical Stage... and other conditionsUnited States
-
University of NottinghamCompletedMultiple SclerosisUnited Kingdom
-
Pipeline Therapeutics, Inc.Completed
-
The Leeds Teaching Hospitals NHS TrustUniversity of LeedsCompleted
-
University of NottinghamSwansea University; Multiple Sclerosis Society UKCompleted
-
University College, LondonUniversity College London HospitalsUnknownMultiple SclerosisUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompleted
-
University of LeedsRecruitingPain | Multiple Sclerosis | Trigeminal NeuralgiaUnited Kingdom
-
Queen Mary University of LondonRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGenetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV MelanomaMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Jazz PharmaceuticalsCompletedMultiple SclerosisUnited Kingdom
-
Edinburgh Napier UniversityScottish Hospital Endowments Research Trust; Pacla Medical LtdCompleted
-
University of NottinghamUnknown
-
University of NottinghamUnknownMultiple SclerosisUnited Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisUnited Kingdom
-
University of NottinghamWithdrawnMultiple SclerosisUnited Kingdom
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
The Leeds Teaching Hospitals NHS TrustUnknownMultiple SclerosisUnited Kingdom
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedStage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous MelanomaUnited States
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Imperial College LondonRecruitingMultiple SclerosisUnited Kingdom
-
Glasgow Caledonian UniversityNHS Lanarkshire; MS Society, UKCompletedMultiple SclerosisUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustTerminatedMultiple SclerosisUnited Kingdom